163 related articles for article (PubMed ID: 7933848)
1. Alterations in glomerular dynamics in congenital, unilateral hydronephrosis.
Hanss BG; Lewy JE; Vari RC
Kidney Int; 1994 Jul; 46(1):48-57. PubMed ID: 7933848
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin or thromboxane receptor antagonism in rats with congenital hydronephrosis.
Vari RC; Boineau FG; Lewy JE
J Am Soc Nephrol; 1993 Feb; 3(8):1522-9. PubMed ID: 8490122
[TBL] [Abstract][Full Text] [Related]
3. Glomerular hemodynamics in rats with chronic sodium depletion. Effect of saralasin.
Steiner RW; Tucker BJ; Blantz RC
J Clin Invest; 1979 Aug; 64(2):503-12. PubMed ID: 457865
[TBL] [Abstract][Full Text] [Related]
4. Thromboxane mediates renal hemodynamic response to infused angiotensin II.
Wilcox CS; Welch WJ; Snellen H
Kidney Int; 1991 Dec; 40(6):1090-7. PubMed ID: 1837063
[TBL] [Abstract][Full Text] [Related]
5. Renal functional reserve in the early stage of experimental diabetes.
De Nicola L; Blantz RC; Gabbai FB
Diabetes; 1992 Mar; 41(3):267-73. PubMed ID: 1551487
[TBL] [Abstract][Full Text] [Related]
6. Renal function in rats with angiotensin II-salt-induced hypertension: effect of thromboxane synthesis inhibition and receptor blockade.
Mistry M; Muirhead EE; Yamaguchi Y; Nasjletti A
J Hypertens; 1990 Jan; 8(1):75-83. PubMed ID: 2157760
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of preservation of glomerular perfusion and filtration during acute extracellular fluid volume depletion. Importance of intrarenal vasopressin-prostaglandin interaction for protecting kidneys from constrictor action of vasopressin.
Yared A; Kon V; Ichikawa I
J Clin Invest; 1985 May; 75(5):1477-87. PubMed ID: 3998146
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II and renal functional reserve in rats with Goldblatt hypertension.
De Nicola L; Keiser JA; Blantz RC; Gabbai FB
Hypertension; 1992 Jun; 19(6 Pt 2):790-4. PubMed ID: 1592482
[TBL] [Abstract][Full Text] [Related]
9. Prevention of thromboxane A2 receptor-mediated pulmonary hypertension by a nonpeptide angiotensin II type 1 receptor antagonist.
Bertolino F; Valentin JP; Maffre M; Jover B; Bessac AM; John GW
J Pharmacol Exp Ther; 1994 Feb; 268(2):747-52. PubMed ID: 8113986
[TBL] [Abstract][Full Text] [Related]
10. Effects of angiotensin II receptor blockade on remnant glomerular permselectivity.
Mayer G; Lafayette RA; Oliver J; Deen WM; Myers BD; Meyer TW
Kidney Int; 1993 Feb; 43(2):346-53. PubMed ID: 7680077
[TBL] [Abstract][Full Text] [Related]
11. Comparison of inhibitory potency by nonpeptide angiotensin II receptor antagonists PD123177 and DuP 753 on proximal nephron and renal transport.
Cogan MG; Liu FY; Wong PC; Timmermans PB
J Pharmacol Exp Ther; 1991 Nov; 259(2):687-91. PubMed ID: 1941617
[TBL] [Abstract][Full Text] [Related]
12. Renal and tubuloglomerular feedback effects of [Sar1,Ala8]angiotensin II in the rat.
Ploth DW; Roy RN
Am J Physiol; 1982 Feb; 242(2):F149-57. PubMed ID: 7039342
[TBL] [Abstract][Full Text] [Related]
13. Effects of selective A1 receptor blockade on glomerular hemodynamics: involvement of renin-angiotensin system.
Munger KA; Jackson EK
Am J Physiol; 1994 Nov; 267(5 Pt 2):F783-90. PubMed ID: 7977781
[TBL] [Abstract][Full Text] [Related]
14. Glomerular immune injury in the rat: the influence of angiotensin II and alpha-adrenergic inhibitors.
Blantz RC; Tucker BJ; Gushwa LC; Peterson OW; Wilson CB
Kidney Int; 1981 Oct; 20(4):452-61. PubMed ID: 6118461
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide and angiotensin II. Glomerular and tubular interaction in the rat.
De Nicola L; Blantz RC; Gabbai FB
J Clin Invest; 1992 Apr; 89(4):1248-56. PubMed ID: 1556186
[TBL] [Abstract][Full Text] [Related]
16. Exaggerated tubuloglomerular feedback activity in genetic hypertension is mediated by ANG II and AT1 receptors.
Brännström K; Morsing P; Arendshorst WJ
Am J Physiol; 1996 May; 270(5 Pt 2):F749-55. PubMed ID: 8928835
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II in adrenergic-induced alterations in glomerular hemodynamics.
Pelayo JC; Ziegler MG; Blantz RC
Am J Physiol; 1984 Nov; 247(5 Pt 2):F799-807. PubMed ID: 6093592
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the renal microvascular effects of angiotensin II antagonist, DuP 753: studies in isolated perfused hydronephrotic kidneys.
Loutzenhiser R; Epstein M; Hayashi K; Takenaka T; Forster H
Am J Hypertens; 1991 Apr; 4(4 Pt 2):309S-314S. PubMed ID: 1854457
[TBL] [Abstract][Full Text] [Related]
19. Proximal nephron and renal effects of DuP 753, a nonpeptide angiotensin II receptor antagonist.
Xie MH; Liu FY; Wong PC; Timmermans PB; Cogan MG
Kidney Int; 1990 Sep; 38(3):473-9. PubMed ID: 2232490
[TBL] [Abstract][Full Text] [Related]
20. Modulating role for thromboxane in the tubuloglomerular feedback response in the rat.
Welch WJ; Wilcox CS
J Clin Invest; 1988 Jun; 81(6):1843-9. PubMed ID: 2968365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]